These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Management plan and delivery of care in Graves' ophthalmopathy patients. Yang M; Perros P Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367 [TBL] [Abstract][Full Text] [Related]
13. [Update on endocrine orbitopathy]. Ponto KA; Kahaly GJ; Pitz S Klin Monbl Augenheilkd; 2009 Feb; 226(2):R13-28; quiz R29-31. PubMed ID: 19206039 [No Abstract] [Full Text] [Related]
14. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy. Azzam I; Tordjman K Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362 [TBL] [Abstract][Full Text] [Related]
15. Graves ophthalmopathy: continuing quest in search of initiating factors and new therapies. Fatourechi V Endocr Pract; 2008; 14(4):412-4. PubMed ID: 18558590 [No Abstract] [Full Text] [Related]
16. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy. Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772 [TBL] [Abstract][Full Text] [Related]
17. Medical approach to ophthalmopathy of Graves' disease. Ivy HK Mayo Clin Proc; 1972 Dec; 47(12):980-5. PubMed ID: 4404646 [No Abstract] [Full Text] [Related]